Transgenomic Selling Surveyor Nuclease Technology to IDT for at Least $4.25M | GenomeWeb

NEW YORK (GenomeWeb) – Transgenomic today announced an agreement to sell the rights to it Surveyor Nuclease technology and assets to Integrated DNA Technologies for a minimum of $4.25 million.

IDT will make a $3.65 million upfront payment with additional payments totaling at least $600,000 in the first year of the agreement. Rights to the Surveyor patents, license, technology, know-how, and trademarks, and all product inventory will be transferred to IDT.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.